Genocea Biosciences Names New CEO

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced the promotion of Chip Clark to president and chief executive officer. Mr. Clark joined Genocea as chief business officer in August 2010 and played a critical role in closing the company’s $35 million round of Series B financing announced last month.

Back to news